Small molecule compound
Product Name
CAS Number
Specification
TP
DMF
Status
Olaparib
763113-22-0
In-house
√
Osimertinib mesylate
1421373-66-1
In-house
Q4 2025
Palbociclib
571190-30-2
In-house
√
Pazopanib
444731-52-6
Q1 2026
Q3 2026
Pilocarpine Hydrochloride
54-71-7
USP, EP, JP
√
Posaconazole
171228-49-2
In-house
√
Pranlukast
150821-03-7
JP
√
Ramelteon
196597-26-9
In-house
√
Relugolix
737789-87-6
Q4 2025
Q2 2026
Resmetirom
920509-32-6
In-house
Q42025
Ribociclib
1211441-98-3
Q3 2025
Q1 2026
Rimegepant
1289023-67-1
Q3 2025
Q1 2026
Ritlecitinib
1792180-81-4
Q3 2025
Q1 2026
Rufinamide
106308-44-5
Q4 2025
Q2 2026
Ruxolitinib (Phosphate)
941678-49-5&1092939-17-7
In-house
√
SNAC
203787-91-1
Q3 2025
Q4 2025
Scopolamine Hydrobromide
114-49-8
Q3 2025
Q1 2026
Seladelpar
851528-79-5
Q3 2026
Q2 2027
Selumetinib
606143-52-6
Q3 2025
Q1 2026
Sitafloxacin Hydrate
163253-35-8
In-house
√